Viridian Therapeutics (VRDN) Competitors $20.82 -0.72 (-3.34%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VRDN vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, and PRVAShould you be buying Viridian Therapeutics stock or one of its competitors? The main competitors of Viridian Therapeutics include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Viridian Therapeutics vs. Hims & Hers Health Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Viridian Therapeutics (NASDAQ:VRDN) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Is VRDN or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Viridian Therapeutics' net margin of -85,127.16%. Hims & Hers Health's return on equity of 10.97% beat Viridian Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Viridian Therapeutics-85,127.16% -70.12% -41.49% Hims & Hers Health 8.19%10.97%8.29% Do institutionals & insiders hold more shares of VRDN or HIMS? 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.7% of Viridian Therapeutics shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, VRDN or HIMS? Viridian Therapeutics has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Do analysts prefer VRDN or HIMS? Viridian Therapeutics presently has a consensus target price of $36.67, indicating a potential upside of 76.11%. Hims & Hers Health has a consensus target price of $22.80, indicating a potential downside of 26.74%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Viridian Therapeutics is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viridian Therapeutics 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41 Which has higher valuation and earnings, VRDN or HIMS? Hims & Hers Health has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViridian Therapeutics$302K5,460.98-$237.73M-$4.31-4.83Hims & Hers Health$872M7.80-$23.55M$0.4470.73 Does the media favor VRDN or HIMS? In the previous week, Viridian Therapeutics and Viridian Therapeutics both had 27 articles in the media. Viridian Therapeutics' average media sentiment score of 0.84 beat Hims & Hers Health's score of 0.39 indicating that Viridian Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viridian Therapeutics 10 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 10 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor VRDN or HIMS? Viridian Therapeutics received 34 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 79.35% of users gave Viridian Therapeutics an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformViridian TherapeuticsOutperform Votes7379.35% Underperform Votes1920.65% Hims & Hers HealthOutperform Votes3938.61% Underperform Votes6261.39% SummaryHims & Hers Health beats Viridian Therapeutics on 10 of the 17 factors compared between the two stocks. Ad Porter & CompanyHiding in the Bible New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.This is the untold, true story of God’s Investment. Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRDN vs. The Competition Export to ExcelMetricViridian TherapeuticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65B$2.93B$5.17B$9.30BDividend YieldN/A11.01%4.77%4.06%P/E Ratio-4.8316.38132.2217.52Price / Sales5,319.85210.801,256.58139.03Price / CashN/A472.0940.7837.95Price / Book4.655.224.904.91Net Income-$237.73M-$32.86M$118.85M$225.61M7 Day Performance7.54%-2.72%14.53%-1.46%1 Month Performance3.38%10.77%17.44%5.38%1 Year Performance8.32%17.27%35.31%22.72% Viridian Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRDNViridian Therapeutics2.9626 of 5 stars$20.82-3.3%$36.67+76.1%+8.3%$1.71B$302,000.00-4.8350Analyst ForecastNews CoverageGap UpHIMSHims & Hers Health3.45 of 5 stars$30.93+3.0%$21.43-30.7%+268.3%$6.76B$872M70.251,046Analyst ForecastInsider TradeShort Interest ↑Gap UpGHGuardant Health3.8131 of 5 stars$35.13+1.1%$40.60+15.6%+23.6%$4.34B$692.26M-8.201,779News CoveragePositive NewsOPCHOption Care Health4.8865 of 5 stars$23.40-0.4%$30.14+28.8%-26.7%$3.98B$4.78B19.747,802Positive NewsSHCSotera Health3.7517 of 5 stars$12.95-1.5%$16.08+24.2%-17.3%$3.67B$1.05B52.603,000Positive NewsVCYTVeracyte4.1747 of 5 stars$43.35+0.3%$41.13-5.1%+49.9%$3.36B$361.05M-288.13790BTSGBrightSpring Health Services2.3919 of 5 stars$18.95+2.1%$18.50-2.4%N/A$3.30B$10.59B-71.3835,000Analyst ForecastLFSTLifeStance Health Group2.0439 of 5 stars$7.79+8.6%$8.70+11.7%+2.9%$2.98B$1.21B-29.509,325Analyst UpgradeNews CoveragePositive NewsGap UpSGRYSurgery Partners3.5574 of 5 stars$22.22+9.1%$36.56+64.5%-35.2%$2.82B$2.74B-42.4213,500Analyst ForecastPositive NewsCONConcentra Group Holdings ParentN/A$21.52+5.0%$28.50+32.4%N/A$2.74B$1.88B0.0011,000Analyst UpgradeGap UpPRVAPrivia Health Group3.2065 of 5 stars$21.42+2.2%$24.80+15.8%-7.8%$2.57B$1.66B209.621,102Analyst ForecastNews Coverage Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors CON Competitors PRVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRDN) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
